论文部分内容阅读
目的探讨2型糖尿病(T2DW)患者微量白蛋白尿(MAU)水平与血糖、血脂及血压水平的相关性。方法选择2型糖尿病患者133例,其中单纯糖尿病38例(对照组),糖尿病合并高血压95例(观察组),检测两组空腹血糖、血脂、微量白蛋白尿水平。结果与对照组比较,观察组MAU、血糖、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-L)水平明显增高,高密度脂蛋白胆固醇(HDL-L)水平降低,与对照组比较差异具有统计学意义(P<0.01)。结论 T2DW患者MAU排出量与血糖、脂质代谢紊乱及血压具有相关性。糖尿病及高血压患者应进行MAU含量的筛查,这有利于糖尿病患者肾病及心血管并发症的早期预防和干预治疗。
Objective To investigate the relationship between microalbuminuria (MAU) and blood glucose, blood lipid and blood pressure in type 2 diabetes mellitus (T2DW). Methods 133 patients with type 2 diabetes mellitus were selected, including 38 cases of simple diabetes mellitus (control group) and 95 cases of diabetes mellitus with hypertension (observation group). The levels of fasting blood glucose, blood lipids and microalbuminuria in both groups were measured. Results Compared with the control group, the levels of MAU, blood glucose, total cholesterol (TC), triglyceride (TG), and low density lipoprotein cholesterol (LDL-L) in the observation group were significantly increased, while the levels of high density lipoprotein cholesterol (HDL-L) Decreased, compared with the control group, the difference was statistically significant (P <0.01). Conclusions The MAU output of T2DW patients is related to the blood glucose, lipid metabolism disorder and blood pressure. Patients with diabetes mellitus and hypertension should be MAU screening, which is conducive to early prevention and intervention of diabetic nephropathy and cardiovascular complications.